G codes: procedures and professional services
1,506 codes, page 4 of 8.
Other codes in this group 200
| Code | Name | Status | Hospitals with prices |
|---|---|---|---|
| HCPCS G8897 | Oral aspirin or other antithrombotic therapy was not prescribed, reason not given | Retired code | |
| HCPCS G8898 | I intend to report the chronic obstructive pulmonary disease (copd) measures group | Retired code | |
| HCPCS G8899 | I intend to report the inflammatory bowel disease (ibd) measures group | Retired code | |
| HCPCS G8900 | I intend to report the sleep apnea measures group | Retired code | |
| HCPCS G8902 | I intend to report the dementia measures group | Retired code | |
| HCPCS G8903 | I intend to report the parkinson's disease measures group | Retired code | |
| HCPCS G8904 | I intend to report the hypertension (htn) measures group | Retired code | |
| HCPCS G8905 | I intend to report the cardiovascular prevention measures group | Retired code | |
| HCPCS G8906 | I intend to report the cataract measures group | Retired code | |
| HCPCS G8908 | Patient documented to have received a burn prior to discharge | Current code | |
| HCPCS G8909 | Patient documented not to have received a burn prior to discharge | Current code | |
| HCPCS G8910 | Patient documented to have experienced a fall within asc | Current code | |
| HCPCS G8911 | Patient documented not to have experienced a fall within ambulatory surgical center | Current code | |
| HCPCS G8912 | Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event | Current code | |
| HCPCS G8913 | Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event | Current code | |
| HCPCS G8914 | Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc | Current code | |
| HCPCS G8915 | Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc | Current code | |
| HCPCS G8916 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time | Current code | |
| HCPCS G8917 | Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time | Current code | |
| HCPCS G8923 | Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function | Current code | |
| HCPCS G8924 | Spirometry results documented (fev1/fvc < 70%) | Current code | |
| HCPCS G8925 | Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms | Retired code | |
| HCPCS G8926 | Spirometry test not performed or documented, reason not given | Retired code | |
| HCPCS G8927 | Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer | Retired code | |
| HCPCS G8928 | Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons) | Retired code | |
| HCPCS G8929 | Adjuvant chemotherapy not prescribed or previously received, reason not given | Retired code | |
| HCPCS G8930 | Assessment of depression severity at the initial evaluation | Retired code | |
| HCPCS G8931 | Assessment of depression severity not documented, reason not given | Retired code | |
| HCPCS G8932 | Suicide risk assessed at the initial evaluation | Retired code | |
| HCPCS G8933 | Suicide risk not assessed at the initial evaluation, reason not given | Retired code | |
| HCPCS G8934 | Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function | Current code | |
| HCPCS G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | Current code | |
| HCPCS G8936 | Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) | Current code | |
| HCPCS G8937 | Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given | Current code | |
| HCPCS G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | Retired code | |
| HCPCS G8939 | Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter | Retired code | |
| HCPCS G8940 | Screening for depression documented as positive, a follow-up plan not completed, documented reason | Retired code | |
| HCPCS G8941 | Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter | Retired code | |
| HCPCS G8942 | Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment | Current code | |
| HCPCS G8943 | Ldl-c result not present or not within 12 months prior | Retired code | |
| HCPCS G8944 | Ajcc melanoma cancer stage 0 through iic melanoma | Current code | |
| HCPCS G8946 | Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells) | Current code | |
| HCPCS G8947 | One or more neuropsychiatric symptoms | Retired code | |
| HCPCS G8948 | No neuropsychiatric symptoms | Retired code | |
| HCPCS G8949 | Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes) | Retired code | |
| HCPCS G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | Current code | |
| HCPCS G8951 | Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible | Retired code | |
| HCPCS G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | Current code | |
| HCPCS G8953 | All quality actions for the applicable measures in the oncology measures group have been performed for this patient | Retired code | |
| HCPCS G8955 | Most recent assessment of adequacy of volume management documented | Current code | |
| HCPCS G8956 | Patient receiving maintenance hemodialysis in an outpatient dialysis facility | Current code | |
| HCPCS G8957 | Patient not receiving maintenance hemodialysis in an outpatient dialysis facility | Retired code | |
| HCPCS G8958 | Assessment of adequacy of volume management not documented, reason not given | Current code | |
| HCPCS G8959 | Clinician treating major depressive disorder communicates to clinician treating comorbid condition | Retired code | |
| HCPCS G8960 | Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given | Retired code | |
| HCPCS G8961 | Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery | Current code | |
| HCPCS G8962 | Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery | Current code | |
| HCPCS G8963 | Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years | Retired code | |
| HCPCS G8964 | Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc) | Retired code | |
| HCPCS G8965 | Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment | Retired code | |
| HCPCS G8966 | Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment | Retired code | |
| HCPCS G8967 | Fda approved oral anticoagulant is prescribed | Current code | |
| HCPCS G8968 | Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment) | Current code | |
| HCPCS G8969 | Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation) | Current code | |
| HCPCS G8970 | No risk factors or one moderate risk factor for thromboembolism | Current code | |
| HCPCS G8971 | Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given | Retired code | |
| HCPCS G8972 | One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism | Retired code | |
| HCPCS G8973 | Most recent hemoglobin (hgb) level < 10 g/dl | Retired code | |
| HCPCS G8974 | Hemoglobin level measurement not documented, reason not given | Retired code | |
| HCPCS G8975 | Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons) | Retired code | |
| HCPCS G8976 | Most recent hemoglobin (hgb) level >= 10 g/dl | Retired code | |
| HCPCS G8977 | I intend to report the oncology measures group | Retired code | |
| HCPCS G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | 1 hospital |
| HCPCS G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8983 | Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8986 | Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8990 | Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8991 | Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8992 | Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8993 | Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G8994 | Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8995 | Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | Retired code | 1 hospital |
| HCPCS G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G8999 | Motor speech functional limitation, current status at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G9004 | Coordinated care fee, risk adjusted low, initial | Current code | |
| HCPCS G9006 | Coordinated care fee, home monitoring | Current code | |
| HCPCS G9007 | Coordinated care fee, scheduled team conference | Current code | 1 hospital |
| HCPCS G9011 | Coordinated care fee, risk adjusted maintenance, level 5 | Current code | |
| HCPCS G9012 | Other specified case management service not elsewhere classified | Current code | 3 hospitals |
| HCPCS G9013 | Esrd demo basic bundle level i | Current code | 2 hospitals |
| HCPCS G9014 | Esrd demo expanded bundle including venous access and related services | Current code | 2 hospitals |
| HCPCS G9016 | Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only] | Current code | 11 hospitals |
| HCPCS G9018 | Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project) | Retired code | 1 hospital |
| HCPCS G9020 | Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) | Retired code | 1 hospital |
| HCPCS G9034 | Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project) | Retired code | |
| HCPCS G9036 | Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project) | Retired code | |
| HCPCS G9050 | Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9051 | Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9052 | Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9053 | Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9054 | Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9055 | Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9056 | Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9057 | Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9058 | Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9059 | Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9060 | Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9061 | Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9062 | Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9063 | Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9064 | Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9065 | Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9066 | Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9067 | Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9068 | Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9069 | Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9070 | Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9071 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9072 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9073 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9074 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9075 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9077 | Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9078 | Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9079 | Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9080 | Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9083 | Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9084 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9085 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9086 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9087 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9088 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9089 | Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9090 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9091 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9092 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9093 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9094 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9095 | Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9096 | Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9097 | Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9098 | Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9099 | Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9100 | Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9101 | Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9102 | Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9103 | Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9104 | Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9105 | Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9106 | Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9107 | Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9108 | Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9109 | Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9110 | Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9111 | Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9112 | Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9113 | Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9114 | Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9115 | Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9116 | Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9117 | Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9123 | Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9124 | Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9125 | Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9126 | Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9128 | Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9129 | Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9130 | Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9131 | Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9132 | Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9133 | Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9134 | Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9135 | Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9136 | Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9137 | Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9138 | Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9139 | Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project) | Current code | |
| HCPCS G9140 | Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours | Current code | |
| HCPCS G9142 | Unverified code (HCPCS Level II G-codes range) | Not in CMS's lists | 1 hospital |
| HCPCS G9147 | Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration | Current code | 2 hospitals |
| HCPCS G9158 | Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G9159 | Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G9160 | Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G9161 | Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting | Retired code | |
| HCPCS G9162 | Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G9163 | Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G9164 | Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting | Retired code | |
| HCPCS G9165 | Attention functional limitation, current status at therapy episode outset and at reporting intervals | Retired code | |
| HCPCS G9166 | Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting | Retired code | |
| HCPCS G9167 | Attention functional limitation, discharge status at discharge from therapy or to end reporting | Retired code |